72 results
8-K
EX-10.1
APTO
Aptose Biosciences Inc
1 May 24
Entry into a Material Definitive Agreement
4:30pm
:
The Chairman/Chief Executive will provide leadership and direction to the Corporation and the Board, facilitate the operations and deliberations of the Board … .
Specific Responsibilities:
Leadership
Chairman
Provides leadership and governance of the Board so as to create the conditions for effectiveness
424B4
APTO
Aptose Biosciences Inc
26 Jan 24
Prospectus supplement with pricing info
5:30pm
provided financial guidance and leadership during the acquisition of Arius by Roche in 2008. He was also the former Chief Financial Officer of Labopharm Inc … and Head of Oncology New Products at Merck & Co, where he was responsible for commercial leadership over the entire Merck oncology pipeline, over 25 assets
8-K
EX-99.1
wnq3bn
30 Nov 23
Aptose Appoints Fletcher Payne Chief Business Officer, Expanding his Executive Role
5:28pm
8-K
EX-99.1
2pxy wkagqrfeqc
10 Aug 23
Aptose Reports Results for the Second Quarter 2023
4:10pm
8-K
EX-99.1
vtywvnaln9sswpj
16 Sep 22
Departure of Directors or Certain Officers
5:15pm
8-K
EX-99.1
vti7 78qmttfsgp8
13 Sep 22
Regulation FD Disclosure
8:44am
8-K
EX-99.1
6s1re3irotr3 mmg
19 Jul 22
Financial Statements and Exhibits
5:53pm
8-K
EX-99.1
vj6msza mwv8
27 Jun 22
Aptose Appoints Fletcher Payne as Senior Vice President, Chief Financial Officer
2:29pm
8-K
EX-99.1
985prwt89
27 Jun 22
Financial Statements and Exhibits
9:55am
8-K
EX-99.1
289a o28ut3jan
9 May 22
Aptose Reports Results for the First Quarter 2022
4:30pm
8-K
ltr7t3
11 Apr 22
Aptose Announces Executive Management Changes
5:04pm
8-K
EX-99.1
lpsexj
11 Apr 22
Aptose Announces Executive Management Changes
5:04pm